- Home
- HUM vs ALC Comparison
HUM vs ALC Comparison
Compare HUM & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUM
- ALC
- Stock Information
- Founded
- HUM 1961
- ALC 1945
- Country
- HUM United States
- ALC Switzerland
- Employees
- HUM N/A
- ALC N/A
- Industry
- HUM Medical Specialities
- ALC Ophthalmic Goods
- Sector
- HUM Health Care
- ALC Health Care
- Exchange
- HUM Nasdaq
- ALC Nasdaq
- Market Cap
- HUM 35.0B
- ALC 40.2B
- IPO Year
- HUM 1993
- ALC N/A
- Fundamental
- Price
- HUM $235.42
- ALC $75.78
- Analyst Decision
- HUM Buy
- ALC Buy
- Analyst Count
- HUM 16
- ALC 11
- Target Price
- HUM $297.60
- ALC $89.96
- AVG Volume (30 Days)
- HUM 1.5M
- ALC 2.2M
- Earning Date
- HUM 11-05-2025
- ALC 11-11-2025
- Dividend Yield
- HUM 1.51%
- ALC 0.29%
- EPS Growth
- HUM N/A
- ALC N/A
- EPS
- HUM 10.68
- ALC 2.10
- Revenue
- HUM $126,362,000,000.00
- ALC $10,185,000,000.00
- Revenue This Year
- HUM $9.85
- ALC $5.87
- Revenue Next Year
- HUM $5.48
- ALC $7.71
- P/E Ratio
- HUM $21.92
- ALC $36.21
- Revenue Growth
- HUM 9.87
- ALC 4.34
- 52 Week Low
- HUM $206.87
- ALC $71.55
- 52 Week High
- HUM $315.35
- ALC $99.20
- Technical
- Relative Strength Index (RSI)
- HUM 31.71
- ALC 49.11
- Support Level
- HUM $230.71
- ALC $72.09
- Resistance Level
- HUM $239.00
- ALC $81.89
- Average True Range (ATR)
- HUM 8.89
- ALC 1.38
- MACD
- HUM -3.97
- ALC 0.31
- Stochastic Oscillator
- HUM 7.55
- ALC 37.45
About HUM Humana Inc.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.